Direct-to-patient (DTP) distribution of clinical supplies provides trial sponsors with the opportunity to support improved recruitment and retention rates for their studies by removing or reducing the travel and time commitments that can otherwise inhibit patients’ willingness and ability to participate.

This webinar reveals results from a recent industry survey that sought to gain insight on trial sponsors’ perspective on offering a DTP option and their current level of awareness and understanding of any factors that may influence their ability to do so.

Topics to be discussed include:

  • Findings among survey respondents around the value of being able to offer DTP, potential approaches and possible challenges
  • Overview of regulatory considerations surrounding DTP in the US and Europe and suggestions on how to create an optimized supply strategy.
  • Review of DTP distribution models including a new regulatory compliant, streamlined approach that bypasses the clinical site



Featured Speakers

Nicole Gray

Director, Strategic Supply Solutions
Catalent Pharma Solutions

Nicole Gray is Director, Strategic Supply Solutions responsible for developing Direct to Patient and other new strategic service offerings.  She has been in the Pharmaceutical industry for 15 years and has held multiple roles in clinical supplies project management, most recently as the Director of Project Management for the Catalent Philadelphia site.  

Nick Taylor

Editor
FiercePharma

Nick Taylor is a writer with more than 10 years' experience of reporting on the global biopharma industry. Since graduating with a biology degree from the University of York, Nick has written for numerous healthcare publications, including FierceBiotech and Nature's BioPharma Dealmakers.

NOW AVAILABLE ON-DEMAND

Register now for this webinar